Keywords: Sanofi, Weill Cornell, Tuberculosis research, Academia

Another academia deal for Sanofi, now with Weill Cornell for tuberculosis drug discovery

Article | 01 July 2011

Print This

Paris, France-based Sanofi (Euronext: SAN) says that it entered into a research collaboration with Weill Cornell Medical College in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in